Since the first HIV products became available nearly two decades ago, Merck has worked to expand access to our medicines, build healthcare infrastructure, and address health and development challenges around the world.
More than 1.2 million people in the U.S. are living with HIV
1 in 8 people living with HIV don’t know it
Approximately 36.9 MILLION
people were living with HIV at
the end of 2014
Approximately 2 MILLION
people became newly infected
with HIV in 2014
It is estimated that currently only 51% of people with HIV know
In the mid-1980s, Merck began its clinical HIV research in response to what the company perceived as a potential epidemic – our scientists were among the first to discover and develop medicines for the treatment of HIV. Today, a future where HIV/AIDS can be a manageable illness is closer, in part, because of Merck’s response to the crisis.LEARN MORE
We continue to explore ways to enhance access to our HIV medicines, particularly in the developing world, and through partnerships that seek to strengthen health systems to better deliver prevention and treatment services. Clearly, the need is too great for any one stakeholder to address, requiring coordinated efforts among many. We are committed to working with governments, donors, innovative and generic manufacturers, multilateral organizations and civil society to address the full range of factors affecting access.LEARN MORE
“ I’m sorry to tell you this…you’ve tested positive for HIV.”
The year was 1995, but Merck HIV Community Liaison Catherine Elliott remembers it as though it happened yesterday.READ CATHERINE’S STORY
The I Design campaign by Merck, in collaboration with music promoter Maria Davis and fashion designer Mondo Guerra, is a national education campaign aimed at empowering the HIV community to have open conversations with their healthcare team about their lifestyle needs, HIV treatment plan and other chronic conditions and/or medicines they may be taking.
The campaign educates patients on the importance of vocalizing individual needs and concerns to their healthcare team so that a tailored treatment plan can be developed.LEARN MORE